COVID-19 impact on therapy drug sales growth in India 2020 by type

Respiratory therapy drugs witnessed the highest sales across India in March 2020 compared to February that same year, recording a growth of nearly 23 percent. This was due to the coronavirus (COVID-19) epidemic and despite a nation-wide lockdown that disrupted distribution of drugs and prescription medicines. On the other hand, segments such as dermatology, gastrointestinal, pain and analgesics, and vaccines showed a decline in sales during the same time period.
The country went into lockdown earlier that week, the largest in the world, restricting 1.3 billion people.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Fact and Figures page.

Sales growth of therapy drugs due to the coronavirus (COVID-19) across India in March 2020, by type

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

April 2020



Survey time period

March 2020

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Pharmaceutical industry in India"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.